CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $45.03 ($61,916)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $46.03 ($63,291)
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $49.50 ($391,077)
- 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
- 4 Exercise or conversion EVP, Research & CSO acquired 3,500 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $43.57 ($242,244)
- 4 Exercise or conversion EVP, Research & CSO acquired 14,000 shares (option exercise)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $51.40 ($356,956)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Grant or award Chief Technology Officer acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $53.60 ($423,408)
- 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
- 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $44.80 ($249,086)
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $63.44 ($440,531)
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $63.74 ($503,577)
- 4 Grant or award CFO acquired 25,000 shares (grant or award)
Page 18 of 25 · 491 filings